South Austin Cancer Center

Austin, TX

Sorting 1 by

Accepting patients

GCO12F CAR-T

A Phase 1b/2 Study of GC012F, a Chimeric Antigen Receptor T-cell (CAR T) Therapy Targeting CD19 and B-cell Maturation Antigen (BCMA) in Subjects With Relapsed/Refractory Multiple Myeloma
Learn more
  • CAR T Cell
  • BCMA
  • CD19
  • Phase 1/2